Sort
130,381 grants matching “hiv”
Activities Of Chemokines In Vivo
$2,888,396Joshua M Farber · Niaid Extramural Activities · Z01 · FY2007 · AI
PS09-962 SUPPORTING THE IMPLEMENTATION AND EZPANSION OF HIGH QUALITY HIV PREV
$2,887,706Benjamin Schwartz · Care Usa · U2G · FY2012 · PS
PS12-1201 COMPREHENSIVE HIV PREVENTION PROJECT FOR HEALTH DEPTS
$2,887,658Andrea Perez · Indiana State Department Of Health · U62 · FY2014 · PS
GH11-1152, S. Africa, Planning, Implementation and Evaluation of Comprehensive HIV Prevention Programs
$2,886,900Debbie Van Zyl · Community Media Trust · U2G · FY2016 · GH
Alabama-Clinical Trials Unit
$2,886,842Michael S. Saag · University Of Alabama At Birmingham · U01 · FY2008 · AI
Recipient Epidemiology and Donor Evaluation Study III (REDS-III) Domestic Hub
$2,884,691Darrell Triulzi · Institute For Transfusion Medicine · N01 · FY2013 · HL
MULTICENTER AIDS COHORT STUDY
$2,884,097Howard Brown Health Center · U01 · FY2005 · AI
The Florida Node Alliance of the National Drug Abuse Treatment Clinical Trials Network
$2,883,414Jose Szapocznik · University Of Miami School Of Medicine · UG1 · FY2022 · DA
Center for AIDS Research
$2,883,369Georgia D Tomaras · Duke University · P30 · FY2025 · AI
IeDEA Asia-Pacific Research Collaboration
$2,883,099Annette H Sohn · Foundation For Aids Research · U01 · FY2024 · AI
HIV PREVENTION PROJECTS
$2,882,626Kathy Donner · Arizona State Department Of Hlth Srvcs · U62 · FY2006 · PS
MACS/WIHS Combined Cohort Study: Brooklyn Clinical Research Site (Bklyn CRS)
$2,882,001Deborah R. Gustafson · Suny Downstate Medical Center · U01 · FY2025 · HL
Surviving the HIV Epidemic (S/HE) in metropolitan Washington DC - Advancing knowledge through cohort studies
$2,881,859Seble G Kassaye · Georgetown University · U01 · FY2020 · HL
MACS/WIHS Combined Cohort Study: Brooklyn Clinical Research Site (Bklyn CRS)
$2,880,797Deborah R. Gustafson · Suny Downstate Medical Center · U01 · FY2020 · HL
Washington Women's Interagency HIV/AIDS Study
$2,880,597Mary A Young · Georgetown University · U01 · FY2013 · AI
Addressing risk through Community Treatment for Infectious disease and Opioid use disorder Now (ACTION) among justice-involved populations
$2,880,406Sandra Ann Springer · Yale University · U01 · FY2022 · DA
Project 3: Pandemic Virus Protease Inhibitors
$2,879,997Reuben S Harris · University Of Minnesota · U19 · FY2022 · AI
Using Longitudinal Research to Engage African American and Latinx Sexual- and Gender-Minority Youth in the HIV Prevention and Care Continua and Reduce HIV/AIDS-Related Disparities
$2,879,967Michele D Kipke · Children'S Hospital Of Los Angeles · U01 · FY2023 · DA
Columbia Collaborative HIV/AIDS Clinical Trials Unit
$2,878,282Scott M Hammer · Columbia University Health Sciences · U01 · FY2008 · AI
FAT REDISTRIBUTION AND METABOLIC CHANGE IN HIV INFECTION
$2,877,297Northern California Institute Res &Educ · R01 · FY2000 · DK
Surviving the HIV Epidemic (S/HE) in metropolitan Washington DC - Advancing knowledge through cohort studies
$2,877,028Seble G Kassaye · Georgetown University · U01 · FY2025 · HL
Development and Evaluation of Dual Compartment Combination Microbicides
$2,876,353Robert Walter Buckheit · Imquest Biosciences · U19 · FY2014 · AI
PA04012, HIV PREVENTION PROJECTS
$2,875,564James M Vergeront · Wisconsin Department Of Health Services · U62 · FY2009 · PS
Health Outcomes around Pregnancy and Exposure to HIV/ARV (HOPE): Extending the Reach of PHACS to Examine Women's Health
$2,875,116Paige L Williams · Harvard University D/B/A Harvard School Of Public Health · R01 · FY2024 · HD
University of North Carolina Global HIV Prevention and Treatment Clinical Trials
$2,873,337Joseph J. Eron · Univ Of North Carolina Chapel Hill · UM1 · FY2018 · AI